PT1069902E - Utilizacao de fosfolipidos na producao de um medicamento para a prevencao de adesoes - Google Patents

Utilizacao de fosfolipidos na producao de um medicamento para a prevencao de adesoes

Info

Publication number
PT1069902E
PT1069902E PT98955792T PT98955792T PT1069902E PT 1069902 E PT1069902 E PT 1069902E PT 98955792 T PT98955792 T PT 98955792T PT 98955792 T PT98955792 T PT 98955792T PT 1069902 E PT1069902 E PT 1069902E
Authority
PT
Portugal
Prior art keywords
phospholipids
production
medicament
prevention medicine
drug prevention
Prior art date
Application number
PT98955792T
Other languages
English (en)
Portuguese (pt)
Inventor
Brian Andrew Hills
Derek Alan Woodcock
Original Assignee
Britannia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Britannia Pharmaceuticals Ltd filed Critical Britannia Pharmaceuticals Ltd
Publication of PT1069902E publication Critical patent/PT1069902E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT98955792T 1998-04-03 1998-11-26 Utilizacao de fosfolipidos na producao de um medicamento para a prevencao de adesoes PT1069902E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9807298.6A GB9807298D0 (en) 1998-04-03 1998-04-03 Medicament

Publications (1)

Publication Number Publication Date
PT1069902E true PT1069902E (pt) 2004-06-30

Family

ID=10829890

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98955792T PT1069902E (pt) 1998-04-03 1998-11-26 Utilizacao de fosfolipidos na producao de um medicamento para a prevencao de adesoes

Country Status (12)

Country Link
US (1) US6719960B1 (enExample)
EP (1) EP1069902B1 (enExample)
JP (1) JP4287050B2 (enExample)
AT (1) ATE259234T1 (enExample)
AU (1) AU1251799A (enExample)
CA (1) CA2327693C (enExample)
DE (1) DE69821655T2 (enExample)
DK (1) DK1069902T3 (enExample)
ES (1) ES2214748T3 (enExample)
GB (2) GB9807298D0 (enExample)
PT (1) PT1069902E (enExample)
WO (1) WO1999051244A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807298D0 (en) 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
AU2002255181A1 (en) * 2001-05-21 2002-12-03 Britannia Pharmaceuticals Limited Use of phospholipids in the treatment of degenerative lung disease such as copd or cystic fibrosis and to enhance delivery of drugs
GB0115505D0 (en) * 2001-06-25 2001-08-15 Britannia Pharmaceuticals Ltd Prevention of surgical adhesions
GB0200704D0 (en) * 2002-01-14 2002-02-27 Britannia Pharmaceuticals Ltd Use of phospholipids in peritoneal dialysis
GB0207653D0 (en) * 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
EP1426053A1 (en) * 2002-12-03 2004-06-09 Fresenius Kabi Deutschland GmbH Use of amphiphilic lipids for reducing tumor metastasis
GB0322448D0 (en) 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
JP4928266B2 (ja) * 2003-10-07 2012-05-09 ノースゲート テクノロジーズ インコーポレイテッド 物質を体腔へ送出するためのシステム及び方法
US7914517B2 (en) * 2003-10-31 2011-03-29 Trudell Medical International System and method for manipulating a catheter for delivering a substance to a body cavity
GB0426010D0 (en) * 2004-11-26 2004-12-29 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
EP2056922B1 (en) 2006-08-04 2018-03-28 Northgate Technologies, Inc. In-dwelling port for access into a body
US8020726B1 (en) * 2006-10-18 2011-09-20 Sandia Corporation Powder dispersion system
US20080241270A1 (en) * 2007-03-30 2008-10-02 Neal Robert A Fluid composition for inhibiting surgical adhesion formation and related method of production
US9572595B1 (en) 2014-03-05 2017-02-21 Northgate Technologies Inc. In-dwelling port for access into a body
GB201511058D0 (en) * 2015-06-23 2015-08-05 Lamellar Biomedical Ltd Compositions and methods for using lamellar bodies for therapeutic purposes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58164513A (ja) * 1982-03-25 1983-09-29 Teijin Ltd 肺表面活性物質及びその調製法
DE3229179C2 (de) * 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
IN166447B (enExample) * 1985-11-27 1990-05-12 Ethicon Inc
WO1991012026A1 (en) 1990-02-14 1991-08-22 Macnaught Pty Limited Means of reducing surgical adhesions
DE69131163T2 (de) 1990-05-18 1999-12-23 Tokyo Tanabe Co., Ltd. Asthma heilmittel
US5438044A (en) * 1992-06-30 1995-08-01 Rhone-Poulenc Rorer Phospholipid composition
AU7685798A (en) 1997-05-29 1998-12-30 Applied Biotechnologies Inc. Compositions and methods for preventing adhesion
GB9807298D0 (en) 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament

Also Published As

Publication number Publication date
AU1251799A (en) 1999-10-25
GB2335853A (en) 1999-10-06
GB9825971D0 (en) 1999-01-20
EP1069902B1 (en) 2004-02-11
WO1999051244A1 (en) 1999-10-14
US6719960B1 (en) 2004-04-13
ATE259234T1 (de) 2004-02-15
EP1069902A1 (en) 2001-01-24
DE69821655T2 (de) 2004-12-23
GB9807298D0 (en) 1998-06-03
CA2327693A1 (en) 1999-10-14
DK1069902T3 (da) 2004-06-07
DE69821655D1 (de) 2004-03-18
ES2214748T3 (es) 2004-09-16
JP4287050B2 (ja) 2009-07-01
CA2327693C (en) 2006-11-21
JP2002510638A (ja) 2002-04-09

Similar Documents

Publication Publication Date Title
PT1069902E (pt) Utilizacao de fosfolipidos na producao de um medicamento para a prevencao de adesoes
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
BR9911071A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido
AR015524A1 (es) FORMULACIoN ESTABLE DE SOLUCIoN DE OXIPLATINO, SU USO PARA LA MANUFACTURA DE UN MEDICAMENTO, PROCESO PARA SU PREPARACIoN, PRODUCTO FARMACÉUTICO QUE LA CONTIENE Y UN MÉTODO PARA ESTABILIZAR UNA SOLUCIoN DE OXALIPLATINO.
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
BR9916694A (pt) Composição de lenço facial e método de uso parasequestração de irritantes cutâneos de secreçãonasal
BR0015284A (pt) Formulações de hidrocodona de liberação controlada
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
MX9306239A (es) Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
JP2008523149A (ja) 体液を調節する薬剤及びその使用方法
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
BR0314854A (pt) Dispositivo médico para difusão de medicamentos
BR9406893A (pt) Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids
ATE146677T1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
EE04997B1 (et) Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine
BR9810832B1 (pt) composição farmacêutica contendo como princìpios ativos vitamina d associada a um sal de cálcio, e, processos para a preparação de uma composição farmacêutica, para o tratamento de deficiências nutricionais de cálcio e vitamina d na velhice e para reduzir a perda de tecido ósseo ligada à idade e para evitar fraturas femurais e outras fraturas não vertebrais.
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
EA200000176A1 (ru) Применение физиологически приемлемых соединений, солей и комплексов ванадия
DE69426530D1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
BR0207866A (pt) Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna
GEP20043231B (en) Resorcinol Composition
ATE280575T1 (de) Transdermales therapeutisches system zur anwendung von candesartan
AR011707A1 (es) Composicion farmaceutica que comprende tirosina y un alergeno opcionalmente modificado, procedimiento para su preparacion y el uso de la misma para la manufactura de un medicamento.
JP2002520292A5 (ja) ヒト成長因子と組み合わせた脈管形成剤としてのコンポーネントｂの使用